Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alexion Pharmaceuticals, Inc. (ALXN)

« Back to company index

ALXN Chatter Timeline

Stock Ticker for ALXN

Most Active Tweeters for ALXN

No tweets found

Recent Tweets for ALXN

registrarjourn @registrarjourn
Alexion Pharmaceuticals $ALXN Stock Rating Reaffirmed by Evercore ISI https://t.co/P9v5A9HlFr
August 22nd 2018, 2:08am
EnterpriseLeade @EnterpriseLeade
Alexion Pharmaceuticals $ALXN Stock Rating Reaffirmed by Evercore ISI https://t.co/tsPpZIPJYf
August 22nd 2018, 2:08am
registrarjourn @registrarjourn
Verity Asset Management Inc. Invests $313,000 in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/YVqqxs9RNC
August 21st 2018, 7:08pm
EnterpriseLeade @EnterpriseLeade
Verity Asset Management Inc. Invests $313,000 in Alexion Pharmaceuticals, Inc. $ALXN https://t.co/TSUTHRQdqv
August 21st 2018, 7:08pm
Backtested @Backtested
Closing the $ALXN position that was opened on Aug 21for a 1.07% gain.
August 21st 2018, 7:08pm
beyond_ninety @beyond_ninety
Vident Investment Advisory Trimmed Its Alexion Pharmaceuticals $ALXN Position; Shorts at Kohls $KSS Lowered By 1.06% https://t.co/72WXh97bNM
August 21st 2018, 6:08pm
usindexlive @usindexlive
Old Mutual Global Investors Uk LTD Lowered Its Nike $NKE Position; Alexion Pharmaceuticals $ALXN Has 1 Sentiment https://t.co/z4McnFsGVX
August 21st 2018, 6:08pm
MareaInformativ @MareaInformativ
Zacks Investment Research Upgrades Alexion Pharmaceuticals $ALXN to “Buy” https://t.co/njT0L8OZSf
August 21st 2018, 5:08pm
sometrader @sometrader
Stewie, what do you think about $ALXN? Is it bottoming here? @AOTtrades https://t.co/FIauSs2hoT
August 21st 2018, 4:08pm
MareaInformativ @MareaInformativ
Alexion Pharmaceuticals, Inc. $ALXN Holdings Trimmed by New Mexico Educational Retirement Board https://t.co/yS0uUTS13F
August 21st 2018, 4:08pm
usindexlive @usindexlive
Tt International Lifted Its Alexion Pharmaceuticals $ALXN Stake; Universal Display $PANL's Sentiment Is 0.98 https://t.co/eBpHkYdMov
August 21st 2018, 3:08pm
beyond_ninety @beyond_ninety
Ardsley Advisory Partners Has Lowered Alexion Pharmaceuticals $ALXN Holding as Market Value Declined; Facebook $FB… https://t.co/3tB21tbiPC
August 21st 2018, 2:08pm
AlgoSniffer @AlgoSniffer
$OLED is a #BullishBuck and $ALXN is a #BearishBuck this morning
August 21st 2018, 1:08pm
fda_tracker @fda_tracker
$ALXN New PDUFA Date 2019-02-18 ALEXION PHARMACEUTICALS, INC. Link:https://t.co/Rj7nGoBUo6 Calendar:https://t.co/sCt1qK7blT
August 21st 2018, 1:08pm
optioncharts @optioncharts
$ALXN open interest for maturity 08/24/2018. High put=116.00 High call=120.00 #maxpain #options… https://t.co/XOVf28yVTW
August 21st 2018, 12:08pm
beyond_ninety @beyond_ninety
Kazazian Asset Management Holds Stake in Alexion Pharmaceuticals $ALXN; Kansas City Southern $KSU Shareholder Jeffe… https://t.co/PYLrdurnPq
August 21st 2018, 9:08am
registrarjourn @registrarjourn
ValuEngine Downgrades Alexion Pharmaceuticals $ALXN to Sell https://t.co/aoxTNrkYXL
August 21st 2018, 6:08am
EnterpriseLeade @EnterpriseLeade
ValuEngine Downgrades Alexion Pharmaceuticals $ALXN to Sell https://t.co/EP1ltSc3CL
August 21st 2018, 6:08am
Investor666 @Investor666
$ALXN Alexion: Priced Right For Long-Term Investors - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) | Seeking Alpha https://t.co/eCnGE0kb5m
August 21st 2018, 5:08am
MareaInformativ @MareaInformativ
Alexion Pharmaceuticals, Inc. $ALXN Given Average Recommendation of “Buy” by Brokerages https://t.co/fCrYsOcU6A
August 20th 2018, 6:08pm
registrarjourn @registrarjourn
Alexion Pharmaceuticals, Inc. $ALXN Given Average Rating of “Buy” by Brokerages https://t.co/kmqOYLZBM5
August 20th 2018, 6:08pm
bdailystocks @bdailystocks
FDA accepts for review $ALXN ’s Biologics License Application for approval of ALXN1210 as a Treatment for Patients… https://t.co/uWhW58d58v
August 20th 2018, 6:08pm
SchoonsNYC @SchoonsNYC
Tried to buy $ALXN three times, but it failed. I decided to short close to 116 as it didn't look like it would be a… https://t.co/vHSTjtUL5w
August 20th 2018, 3:08pm
IBD_AGatlin @IBD_AGatlin
Alexion Pharma could grab another approval in early 2019 $ALXN https://t.co/0204CW3FaN
August 20th 2018, 2:08pm
kuritzmike @kuritzmike
RT @BioStocks: $ALXN FDA Accepts Priority Review of ALXN1210 BLA as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)…
August 20th 2018, 1:08pm
beyond_ninety @beyond_ninety
Alexion Pharmaceuticals $ALXN Shareholder Edge Wealth Management Lowered Its Stake by $457,431; As Array Biopharma… https://t.co/AZofXlaSDH
August 20th 2018, 11:08am
TopStockAlerts1 @TopStockAlerts1
Alexion Pharma $ALXN FDA Accepts Priority Review of ALXN1210 as Treatment for Patients with PNH
August 20th 2018, 11:08am
BioBounce @BioBounce
RT @AlgoSniffer: $ONCE is a #BullishBuck and $ALXN is a #BearishBuck this morning
August 20th 2018, 9:08am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $ALXN (+2.1% pre) Alexion Pharma FDA Accepts Priority Review of ALXN1210 as Treatment for Patients with PNH - SI https:/…
August 20th 2018, 8:08am
OpenOutcrier @OpenOutcrier
$ALXN (+2.1% pre) Alexion Pharma FDA Accepts Priority Review of ALXN1210 as Treatment for Patients with PNH - SI https://t.co/SYcPCYoBht
August 20th 2018, 8:08am
Briefingcom @Briefingcom
$ALXN: Alexion Pharma announces that the FDA has accepted for priority review the Biologics License Application for… https://t.co/c19MzwOoHR
August 20th 2018, 8:08am
usindexlive @usindexlive
Pura Vida Investments Has Cut Alexion Pharmaceuticals $Put $ALXN Holding as Market Value Declined; Poplar Forest Ca… https://t.co/V2ojFwcrJ4
August 20th 2018, 8:08am
edtaussig @edtaussig
RT @odibro: $ALXN FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with PNH in the US. PDUFA February 18, 2019 https://t…
August 20th 2018, 7:08am
MarketCurrents @MarketCurrents
FDA accepts priority review of ALXN1210 as a treatment for patients with PNH in the US https://t.co/zs5G7mdyL3 #premarket $ALXN
August 20th 2018, 7:08am
Allstocknews @Allstocknews
$ALXN FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobi From our Stock News Alerts App
August 20th 2018, 6:08am
BioStocks @BioStocks
$ALXN FDA Accepts Priority Review of ALXN1210 BLA as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). PDUFA 02/18/19
August 20th 2018, 6:08am
odibro @odibro
$ALXN FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with PNH in the US. PDUFA February 18, 20… https://t.co/KvqLfYGxdH
August 20th 2018, 6:08am
The_CasualSmart @The_CasualSmart
Alexion Pharmaceuticals $ALXN Shareholder Tourbillon Capital Partners LP Cut Its Stake by $32.43 Million as Valuati… https://t.co/uq5DlCS6Ka
August 20th 2018, 5:08am
MareaInformativ @MareaInformativ
Evercore ISI Reiterates “Outperform” Rating for Alexion Pharmaceuticals $ALXN https://t.co/9TEyrqH2M6
August 20th 2018, 1:08am
optioncharts @optioncharts
$ALXN high OI range is 116.00 to 130.00 for option expiration 08/24/2018 #maxpain #options https://t.co/BeFohiHngr https://t.co/8xc5EYNJl4
August 19th 2018, 12:08pm
beyond_ninety @beyond_ninety
Springbok Capital Management Decreased Its Alexion Pharmaceuticals $Call $ALXN Holding; Convergence Investment Part… https://t.co/hRUWsHnM9w
August 19th 2018, 11:08am
beyond_ninety @beyond_ninety
As Alexion Pharmaceuticals $ALXN Stock Declined, Premier Asset Managment Has Boosted Holding; Waters Parkerson & Co… https://t.co/n0GA1XL7F2
August 19th 2018, 11:08am
usindexlive @usindexlive
Sands Capital Management Trimmed Its Alexion Pharmaceuticals $ALXN Position as Market Valuation Declined; Altisourc… https://t.co/d08wZohjy9
August 19th 2018, 11:08am
usindexlive @usindexlive
Alibaba Group Hldg LTD $ALXN Shareholder Tt International Boosted Holding; Visa $V Holder Generation Investment Man… https://t.co/qyFFLa3PmV
August 19th 2018, 8:08am
bbnsnews @bbnsnews
BidaskClub Downgrades Alexion Pharmaceuticals $ALXN to Sell https://t.co/ZcnK8lMbxp
August 19th 2018, 6:08am
ZolmaxNews @ZolmaxNews
BidaskClub Downgrades Alexion Pharmaceuticals $ALXN to Sell https://t.co/6BkkZV24uX
August 19th 2018, 4:08am
4thQuarterCap @4thQuarterCap
I’m not sure what I’m missing with $AKTX here. 52 week lows, trading at cash, low float, tiny marketcap vs. $ALXN a… https://t.co/hNuqdCi2fe
August 19th 2018, 1:08am
TheMarketsDaily @TheMarketsDaily
Alexion Pharmaceuticals $ALXN Downgraded by BidaskClub https://t.co/cTdpr2c4yL
August 18th 2018, 2:08pm
TranscriptDaily @TranscriptDaily
Alexion Pharmaceuticals $ALXN Upgraded at Zacks Investment Research https://t.co/h5J1mRUoC2
August 18th 2018, 2:08pm
beyond_ninety @beyond_ninety
Alexion Pharmaceuticals $ALXN Holder Factory Mutual Insurance Company Lifted Holding; Home Depot $HD Market Valuati… https://t.co/BZau6StvYm
August 18th 2018, 9:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.